Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;18(1):79-94.
doi: 10.1111/iwj.13496. Epub 2020 Nov 25.

Management of incontinence-associated dermatitis: A systematic review of monetary data

Charlotte Raepsaet  1 , Anika Fourie  1 , Ann Van Hecke  1 , Sofie Verhaeghe  1 , Dimitri Beeckman  1   2   3   4   5
Affiliations

Management of incontinence-associated dermatitis: A systematic review of monetary data

Charlotte Raepsaet et al. Int Wound J. 2021 Feb.

Abstract

The objective was to systematically review monetary data related to management of incontinence-associated dermatitis (IAD) in an adult population. Six electronic databases were searched: MEDLINE, CINAHL, Web of Science, EMBASE, The Cochrane Library and EconLit. The search string combined index terms and text words related to IAD and monetary data. The quality of the articles was assessed using the consensus on Health Economic Criteria. Results were synthesised narratively because of methodological heterogeneity. Nine studies were included. Only direct medical costs were reported. The product cost per application for prevention ranged between $0.05 and $0.52, and for treatment between $0.20 and $0.35. The product cost per patient/day for prevention ranged between $0.23 and $20.17. The product cost of IAD prevention and treatment per patient/day ranged between $0.57 and $1.08. The cost to treat IAD did not consider the treatment of secondary infection. The calculation of labour cost and total cost differed considerably between studies. Summarising monetary data is a challenge because of heterogeneity in currencies, settings, samples, time horizons, health- and cost outcome valuation, IAD definition and measurements, and included costs. Procedures for health economic evaluations are to be clarified to guarantee valid interpretation and comparison with other studies.

Keywords: health economic evaluation; incontinence-associated dermatitis; monetary data; prevention; systematic review.

PubMed Disclaimer

Conflict of interest statement

All authors declare: all authors had financial support from Essity Hygiene and Health AB, Gothenburg for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work. The funder had no role in the design of the review, data collection, analyses, interpretation of the results, or the development and submission of the manuscript.

Figures

FIGURE 1
FIGURE 1
PRISMA flowchart
See this image and copyright information in PMC

References

    1. World Health Organization. International classification of diseases for mortality and morbidity statistics 2018. https://icd.who.int/browse11/l-m/en (accessed 25 March 2020)
    1. Gray M, Black JM, Baharestani MM, et al. Moisture‐associated skin damage: overview and pathophysiology. J Wound Ostomy Continence Nurs. 2011;38(3):233‐241. 10.1097/WON.0b013e318215f798 - DOI - PubMed
    1. McNichol LL, Ayello EA, Phearman LA, et al. Incontinence‐associated dermatitis: state of the science and knowledge translation. Adv Skin Wound Care. 2018;31(11):502‐513. 10.1097/01.Asw.0000546234.12260.61 - DOI - PubMed
    1. Campbell J, Cook JL, Doubrovsky A, Vann A, McNamara G, Coyer F. Exploring Incontinence‐Associated Dermatitis in a single centre intensive care unit: a longitudinal point prevalence survey. J Wound Ostomy Continence Nurs. 2019;46(5):401‐407. 10.1097/won.0000000000000571 - DOI - PubMed
    1. Johansen E, Bakken LN, Duvaland E, et al. Incontinence‐associated dermatitis (IAD): prevalence and associated factors in 4 hospitals in southeast Norway. J Wound Ostomy Continence Nurs. 2018;45(6):527‐531. 10.1097/won.0000000000000480 - DOI - PubMed

Publication types